PhRMA Statement on National Governors Association’s Prescription Drug Abuse Reduction Policy Academy

PhRMA Statement on National Governors Association’s Prescription Drug Abuse Reduction Policy Academy

Washington, D.C. (April 2, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) State Government Affairs Senior Vice President Jeffrey Bond issued the following statement regarding a new partnership with National Governors Association today:

"As part of our ongoing efforts to stem the rising tide of prescription drug abuse, PhRMA is proud to support a new year-long policy program, The Prescription Drug Abuse Reduction Policy Academy, developed by the National Governors Association (NGA) and led by Alabama Governor Robert Bentley and Colorado Governor John Hickenlooper.

"America’s pharmaceutical research and biotechnology companies lead the world in discovering and developing innovative medical therapies that have revolutionized health care, helping patients to live longer, healthier and more productive lives. At the same time, the misuse and abuse of those medicines can be deadly, and we have long worked to ensure patients not only have access to the medicines they need, but are educated on the proper use and disposal of those medicines.

"The NGA and PhRMA share the common goal of reducing prescription drug abuse, and this year-long exercise will include not only Alabama and Colorado, but pilots in five selected states. Governors Bentley and Hickenlooper, NGA staff and the Policy Academy partners will work with seven teams of senior-level policymakers to develop state tools for reducing prescription drug abuse. These teams will comprise governors’ health and criminal justice advisors, state health officials, attorneys general, state chief information officers, legislators, physicians and allied health professional groups, and will examine a variety of issues, including:

  • Expanding state prescription drug monitoring program and implementing privacy safeguards;
  • Assessing legislative, regulatory and information exchange barriers;
  • Developing a coordinated state response across agencies;
  • Coordinating across states and within regions;
  • Examining best practices in treatment;
  • Responding to illicit access points such as online pharmacies; and
  • Coordinating education, tracking and monitoring, proper medication disposal and enforcement efforts.

"PhRMA has a strong history of partnering with groups like the NGA, Partnership at Drugfree.org, D.A.R.E America and the Community Anti-drug Coalition of America (CADCA) in developing prescription drug abuse curriculum for students and educators alike. The Policy Academy program is a welcome addition to the breadth of programs supported by America’s pharmaceutical companies in response to national concerns about prescription drug abuse.

"The Policy Academy reinforces that addressing the problem of non-medical use of prescription drugs is a shared responsibility and all stakeholders, including healthcare providers, generic and name brand manufacturers, medical associations, law enforcement, faith-based and other community organizations, schools and colleges, parents, pharmacists, and state and local governments – must continue to work together to prevent prescription drug abuse and misuse."


The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $49.4 billion in 2010 in discovering and developing new medicines. Industry-wide research and investment reached a record $67.4 billion in 2010. 

Find PhRMA Online:

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org

More On PhRMA — powered by PhRMApedia